AU2002335654B2
(en )
2008-02-21
Methods for preparing compositions comprising heat shock proteins or alpha-2-macroglobulin
US20010034042A1
(en )
2001-10-25
Complexes of peptide-binding fragments of heat shock proteins and their use as immunotherapeutic agents
US6007821A
(en )
1999-12-28
Method and compositions for the treatment of autoimmune disease using heat shock proteins
EP1054683B1
(en )
2007-04-11
Modified heat shock protein-antigenic peptide complex
AU2001266694C1
(en )
2005-09-01
Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy
AU2002335654A1
(en )
2003-05-29
Methods for preparing compositions comprising heat shock proteins or alpha-2-macroglobulin
US20020037290A1
(en )
2002-03-28
Compositions comprising heat shock proteins or alpha(2) macroglobulin, antigenic molecules and saponins, and methods of use thereof
AU2001266694A1
(en )
2002-02-28
Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy
US20020192230A1
(en )
2002-12-19
Therapeutic formulations using heat shock/stress protein-peptide complexes
JP2005529124A
(ja )
2005-09-29
免疫応答を上昇させるための熱ショックタンパク質の使用
JP2006507272A
(ja )
2006-03-02
熱ショックタンパク質−ペプチド複合体またはα−2−マクログロブリン−ペプチド複合体を含むワクチンに対する免疫応答を増強するための熱ショックタンパク質およびα−2−マクログロブリンの使用
WO2001052890A1
(en )
2001-07-26
Heat shock/stress protein complexes as vaccines against neurodegenerative disorders
WO2001052877A1
(en )
2001-07-26
Compositions and methods to treat neurodegenerative disorders
ZA200401714B
(https= )
2006-08-30
AU2008202255A1
(en )
2008-06-12
Methods for preparing compositions comprising heat shock proteins or alpha-2-macroglobulin useful for the treatment of cancer and infectious disease